BUY Syngene International Limited — Macquarie
byMacquarieHorizon: NA (inferred 1 year)30 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·1 Sept · 2mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·22 Oct · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Syngene International
- BUY — Rahul Sharma, JM Financial21 Oct 2026 · ~2 weeks · target ₹440 · SL hit
- BUY — Nirav Chheda, Nirmal Bang Securities13 Oct 2026 · ~2 weeks · target ₹410 · Active
- BUY — Goldman Sachs1 Sept 2026 · ~1 year · target ₹450 · Active
- BUY — Jatin Gedia, TM Investment Technologies27 Aug 2026 · ~2 weeks · target ₹430 · SL hit
- BUY — Manas Jaiswal16 Apr 2026 · ~2 weeks · target ₹455 · SL hit
More from Macquarie
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹860 · Active
- BUY Oil and Natural Gas Corporation15 Oct 2026 · ~1 year · target ₹260 · Active
- BUY Hitachi Energy India12 Oct 2026 · ~1 year · target ₹38,500 · Active
- BUY Titan Company7 Oct 2026 · ~1 year · target ₹5,600 · Active
- SELL Mankind Pharma7 Oct 2026 · ~1 year · target ₹2,200 · Active

